Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review
- PMID: 27599097
- DOI: 10.1590/1519-6984.11115
Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review
Abstract
The treatment of sialorrhea is necessary for the constant risks posed by hypersalivation. A new therapeutic option comes up with the application of botulinum toxin in salivary glands. However, little is known about its mechanism of action in glandular tissue. Based on the above, this work had the objective to systematically review the literature about the action of botulinum toxin on submandibular and parotid salivary glands tissues. Electronic search was performed in databases of great relevance for this study (PubMed, SciELO, HighWire, Crossref, Scopus, Science Direct, MEDLINE, OLDMEDLINE, Serials Database, NLM Catalog, LILACS and IBECS). Inclusion and exclusion criteria for articles were established, and a total number of 14 articles were selected and used. There are few publications that clarify how the salivary gland acini behave with application of botulinum toxin. Although, the immunohistochemical findings were consistent among authors, showing weak immunoreactivity in glands treated with botulinum toxin. Histometric data are divergent, requiring more detailed studies to answer the questions about the efficacy and safety of botulinum toxin in salivary glands.
Similar articles
-
Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.Eur Ann Otorhinolaryngol Head Neck Dis. 2022 Mar;139(2):77-81. doi: 10.1016/j.anorl.2021.06.007. Epub 2021 Jun 30. Eur Ann Otorhinolaryngol Head Neck Dis. 2022. PMID: 34217684
-
Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.Med Hypotheses. 1997 Apr;48(4):337-9. doi: 10.1016/s0306-9877(97)90103-1. Med Hypotheses. 1997. PMID: 9160288
-
Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.Neurology. 2008 Jan 22;70(4):316-8. doi: 10.1212/01.wnl.0000300421.38081.7d. Neurology. 2008. PMID: 18209205 Clinical Trial. No abstract available.
-
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.Toxicon. 2015 Dec 1;107(Pt A):129-40. doi: 10.1016/j.toxicon.2015.08.014. Epub 2015 Aug 30. Toxicon. 2015. PMID: 26327120 Review.
-
Sialorrhea in Parkinson's Disease.Toxins (Basel). 2020 Oct 31;12(11):691. doi: 10.3390/toxins12110691. Toxins (Basel). 2020. PMID: 33142833 Free PMC article. Review.
Cited by
-
Botulinum toxin therapy: functional silencing of salivary disorders.Acta Otorhinolaryngol Ital. 2017 Apr;37(2):168-171. doi: 10.14639/0392-100X-1608. Acta Otorhinolaryngol Ital. 2017. PMID: 28516981 Free PMC article. Review.
-
Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions.Neurol Ther. 2020 Jun;9(1):117-133. doi: 10.1007/s40120-020-00182-8. Epub 2020 Mar 12. Neurol Ther. 2020. PMID: 32162214 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical